Ivwatch, LLC
ivWatch is a medical device company dedicated to improving patient safety in infusion therapy and vascular access through innovative continuous monitoring technology. Their flagship product, the ivWatch Model 400, is a first-of-its-kind device that detects IV infiltrations early, reducing patient harm and healthcare costs. The company collaborates with medical professionals and organizations to develop and deploy their life-saving technology, aiming to make IV failure a thing of the past.
Industries
Nr. of Employees
medium (51-250)
Ivwatch, LLC
700 Tech Center Pkwy, Suite 300, Newport News, VA 23606
Patents
System and method for mitigating the effects of tissue blood volume changes to aid in diagnosing infiltration or extravasation in animalia tissue
US-9326686-B2
View Details
System and method for mitigating the effects of tissue blood volume changes to aid in diagnosing infiltration or extravasation in animalia tissue
US-9326686-B2
View DetailsProducts
Continuous IV infiltration monitoring system
Integrated system combining a non-invasive optical sensor, disposable sensor receptacle, and a pole-mounted monitor with algorithms to detect peripheral IV infiltration and extravasation and notify clinicians.
Surgical N95 respirator product line (respirator)
Surgical N95 respirator product offering made available through a dedicated product channel.
Continuous IV infiltration monitoring system
Integrated system combining a non-invasive optical sensor, disposable sensor receptacle, and a pole-mounted monitor with algorithms to detect peripheral IV infiltration and extravasation and notify clinicians.
Surgical N95 respirator product line (respirator)
Surgical N95 respirator product offering made available through a dedicated product channel.
Services
Partnerships to integrate monitoring technology into partner devices and to provide OEM solutions.
Collaboration with hospitals and clinical centers to design and run pilot and multi-phase studies evaluating device performance and clinical outcomes.
Development and operation of on-site manufacturing processes, testing, and production lines for medical devices with adherence to regulated quality standards.
Partnerships to integrate monitoring technology into partner devices and to provide OEM solutions.
Collaboration with hospitals and clinical centers to design and run pilot and multi-phase studies evaluating device performance and clinical outcomes.
Development and operation of on-site manufacturing processes, testing, and production lines for medical devices with adherence to regulated quality standards.
Expertise Areas
- Peripheral IV monitoring and vascular access
- Clinical trial design and execution (including pediatrics)
- Optical biosensing and instrumentation
- Signal processing for biomedical sensors
Key Technologies
- Visible and near-infrared optical sensing
- Continuous patient monitoring systems
- Signal processing algorithms for optical biosensing
- Motion artifact mitigation methods
News & Updates
ivWatch provided its Model 400 devices to help monitor pediatric patients during a mission to St. Vincent and the Grenadines, supporting critical care delivery.
ivWatch announced the issuance of a U.S. patent for solving motion issues related to continuous peripheral IV therapy monitoring, enhancing the reliability of their detection technology.
ivWatch's Model 400 received FDA clearance for early detection of IV infiltrations, representing a significant advancement in patient safety and reducing complications associated with IV therapy.
ivWatch was awarded first place in the Virginia Velocity Business Plan competition for its innovative device that enhances IV safety.
ivWatch received the 2016 Virginia Governor’s Outstanding STEM Award for their innovative device that detects IV infiltrations early, helping to reduce patient harm.
ivWatch provided its Model 400 devices to help monitor pediatric patients during a mission to St. Vincent and the Grenadines, supporting critical care delivery.
ivWatch announced the issuance of a U.S. patent for solving motion issues related to continuous peripheral IV therapy monitoring, enhancing the reliability of their detection technology.
ivWatch's Model 400 received FDA clearance for early detection of IV infiltrations, representing a significant advancement in patient safety and reducing complications associated with IV therapy.
ivWatch was awarded first place in the Virginia Velocity Business Plan competition for its innovative device that enhances IV safety.
ivWatch received the 2016 Virginia Governor’s Outstanding STEM Award for their innovative device that detects IV infiltrations early, helping to reduce patient harm.